Deepika Rachel Pakianathan
Independent Non-Executive DirectorDr. Deepika Rachel Pakianathan, also known as Deepa, Ph.D., was Director of Theravance Biopharma Us, Inc. from July 2020. Dr. Pakianathan had been Independent Director at Theravance Biopharma, Inc. since July 1, 2020 until September 23, 2026. She served as Independent Director at FS Development Corp. since August 12, 2020 until 2021. She has been a Managing Member at Delphi Ventures since 2001 and leads its biotechnology investment activities. Dr. Pakianathan was Managing Partner and General Partner at Delphi. Dr. Pakianathan served as Vice President of the Healthcare Group and a Senior Biotechnology Banker at JPMorgan Chase & Co. from 1998 to 2001. She was a biotechnology research analyst at Genesis Merchant Group from 1997 to 1998. She has experience as a venture capital investor and director of multiple biotechnology companies as well as has experience as a biotechnology investment banker, research analyst and research scientist. Dr. Pakianathan worked as a Postdoctoral Scientist in the Immunology Department at Genentech Corporation from 1993 to 1997, where she evaluated chemokines and chemokine receptors as targets for therapeutic interventions in asthma, HIV infection and multiple sclerosis. She has been an Independent Director of Karyopharm Therapeutics Inc. since April 2013. Dr. Pakianathan serves as an Independent Non-Executive Director of Mereo BioPharma Group plc. since April 23, 2019. Dr. Pakianathan serves as a Director of The National Venture Capital Association, Alexza Molecular; Delivery Corporation. She had been a Director of Calithera Biosciences, Inc. since September 2012 until December 2023 and served as its Lead Independent Director since January 2017 until December 2023. She served as Director of Alder Biopharmaceuticals, Inc., since December 2007 until May 23, 2019. She was Director of FS Development Corp II, from February 2021 to December 2021. She served as a Director of OncoMed Pharmaceuticals, Inc. since December 2008 until 2019. She served on the board of directors of Proteolix, Inc. since May 31, 2006. She is also the Chief Executive Officer of Redd Pharmaceuticals, Inc., a pharmaceuticals company, since September 2019. She serves Executive Vice Chair and Treasurer on the Board of Trustees of the San Francisco Conservatory of Music and on the BIO Emerging Company Board. Dr. Pakianathan served as a Director of ActivBiotics, Inc. She served as a Director of Alexza Pharmaceuticals Inc. from 2004 to 2016. From 2009 to February 2013, she served as a Director at Adiana, Inc. and Intarcia Therapeutics, Inc. She served as Director of Salmedix Inc., since June 2002. Dr. Pakianathan served as Director of Proacta Therapeutics Limited since February 7, 2007; Proacta, Inc. since 2007, Phenomix Corporation since April 2005; Ilypsa, Inc. since July 19, 2005; and Onyx Therapeutics, Inc., since June 2006. She served as a Director of Wake Forest University, NeurAxon, Inc. and Antipodean Pharmaceuticals, Inc. She served as a Director of PTC Therapeutics, Inc from December 2009 to March 7, 2013. She also served as Director of Relypsa, Inc. from 2007 to 2012. From 2007 to 2019, Dr. Pakianathan served on the board of directors of Alder Pharmaceuticals, Inc. Dr. Pakianathan received her Ph.D. in Immunology in 1993 and an M.S. in Biology in 1990, both from the Wake Forest University; M.Sc. in Biophysics from The Cancer Research Institute at University of Mumbai, India. and a B.Sc. from the University of Mumbai, India.
Positions
- Company NameMereo BioPharma Group plcStock CodeMREOPositionIndependent Non-Executive DirectorColleagues
- DVDenise Vera Scots-KnightCo-Founder, CEO & Executive Director
- MSMichael Stephen WyzgaIndependent Non-Executive Chairman of The Board
- CECharles Edward SermonCo-Founder, General Counsel, Business Development & Company Secretary
- CFChristine FoxChief Financial Officer
- JAJohn A. LewickiChief Scientific Officer
- BLBal LallyVP & Head of HR
- AEAnders EkblomIndependent Non-Executive Director
- DRDeepika Rachel PakianathanIndependent Non-Executive Director
- JBJeremy BenderIndependent Non Executive Director
- Company NameKaryopharm Therapeutics Inc.Stock CodeKPTIQPositionIndependent DirectorColleagues
- RARichard A. PaulsonPresident, CEO & Director
- SPStuart PoultonExecutive VP & Chief Development Officer
- RRReshma RangwalaExecutive VP, Chief Medical Officer & Head of Research
- SSSharon ShachamCo-Founder & Chairman of Scientific Advisory Board
- LALori A. MacomberEVP, CFO & Treasurer
- BEBarry E. GreeneLead Independent Director
- GGGaren G. BohlinIndependent Director
